Insertable cardiac monitors detected a higher incidence of atrial fibrillation in patients with prior ischemic stroke over a three-year period than standard medical monitoring methods, according to ...

Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the American Medical Association (JAMA). AMALFI ...

Please provide your email address to receive an email when new articles are posted on . Insertable cardiac monitoring was estimated to be cost-effective for AF detection in the U.S. This finding was ...

Smartwatch screening detects atrial fibrillation earlier and more often, offering a scalable strategy to improve stroke ...

Patients with atrial fibrillation who use wearable devices, like Apple Watches and FitBits, report higher anxiety levels and increased health care usage than nonusers. Although there are concerns ...

Lu Chen, M.D., is a cardiologist specializing in electrophysiology with MyMichigan Physicians Group.

Researchers from two Lithuanian universities have developed a patient-safe monitoring technology to identify and manage individual factors provoking atrial fibrillation. The technology is a result of ...

Asymptomatic AFib is a silent condition, so it often goes undetected until a routine physical, smart technology alert, or a ...

Verily, Alphabet’s life sciences research arm, is collaborating with San Francisco-based iRhythm Technologies to develop digital health tools for screening, diagnosis and management of atrial ...

SAN FRANCISCO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) announced results from the Oxford University-led Active Monitoring for AtriaL FIbrillation (AMALFI) randomized ...